Avraham Gabay - 11 Feb 2025 Form 4 Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
Chief Financial Officer
Signature
/s/ Avraham Gabay
Issuer symbol
ORMP
Transactions as of
11 Feb 2025
Net transactions value
$0
Form type
4
Filing time
11 Feb 2025, 16:30:51 UTC
Previous filing
06 Jan 2025
Next filing
02 Jan 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Award $0 +34,000 +9.5% $0.000000 392,040 11 Feb 2025 Direct F1
transaction ORMP Common Stock Award $0 +42,000 +11% $0.000000 434,040 11 Feb 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares issued on settlement of performance stock units ("PSUs") previously granted on June 20, 2024 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.
F2 Represents shares issued on settlement of PSUs previously granted on January 2, 2025 that vested on February 11, 2025 based on the achievement of the applicable performance criteria.